Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	1. patients with history of hypersensitivity to the study drug 2. female patients, either who are or may be pregnant or who are breastfeeding, or female patients of child-bearing potential who are unable to use adequate contraception during the study 3. patients who are deemed to ineligible to participate in the study for other reasons by the investigator	1. patients with history of hypersensitivity to the study drug 2. female patients, either who are or may be pregnant or who are breastfeeding, or female patients of child-bearing potential who are unable to use adequate contraception during the study 3. patients who are deemed to ineligible to participate in the study for other reasons by the investigator
Nov. 16, 2021, 6:30 p.m.	usa	patients with history of hypersensitivity to the study drug female patients, either who are or may be pregnant or who are breastfeeding, or female patients of child-bearing potential who are unable to use adequate contraception during the study patients who are deemed to ineligible to participate in the study for other reasons by the investigator	patients with history of hypersensitivity to the study drug female patients, either who are or may be pregnant or who are breastfeeding, or female patients of child-bearing potential who are unable to use adequate contraception during the study patients who are deemed to ineligible to participate in the study for other reasons by the investigator
May 5, 2021, 11:25 a.m.	usa	1. patients with history of hypersensitivity to the study drug 2. female patients, either who are or may be pregnant or who are breastfeeding, or female patients of child-bearing potential who are unable to use adequate contraception during the study 3. patients who are deemed to ineligible to participate in the study for other reasons by the investigator	1. patients with history of hypersensitivity to the study drug 2. female patients, either who are or may be pregnant or who are breastfeeding, or female patients of child-bearing potential who are unable to use adequate contraception during the study 3. patients who are deemed to ineligible to participate in the study for other reasons by the investigator